Kazia Therapeutics (KZIA) Income from Discontinued Operations (2011 - 2016)
Kazia Therapeutics (KZIA) posted Income from Discontinued Operations of 48788.05 for Q4 2016, up 1106.37% on a QoQ basis from 4044.2 in Q4 2011.
Kazia Therapeutics (KZIA) Income from Discontinued Operations (2011 - 2016) Analysis & Trends
Kazia Therapeutics' Income from Discontinued Operations history runs 2 years deep, the most recent figure standing at 48788.05 for Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Kazia Therapeutics | 19.14 Bn | 19.14 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 48,788.05 |
| Dec 31, 2011 | 4,044.20 |